Business Wire

Blue Yonder Acquires Optoro to Further Transform Returns Management and Extend Capabilities

19.8.2025 14:02:00 CEST | Business Wire | Press Release

Share

Product returns create friction for consumers, negatively impact profit margins for companies, and result in significant inefficiencies in inventory utilization throughout the supply chain. To combat these challenges, Blue Yonder, the world leader in end-to-end digital supply chain transformation, announced today it has acquired Optoro, Inc., a leading technology provider for returns, to enhance its Returns Management capabilities, delivering a more robust, comprehensive solution.

Returns processing both in the warehouse and in-store is a complex part of the returns lifecycle, especially since 9.5 billion pounds of returns end up in landfills. Blue Yonder identified Optoro’s robust returns processing capabilities, especially for major retailers and brands with a high volume of returns, as a way to further strengthen its capabilities in this space. With Optoro’s and Blue Yonder’s solutions coming together into a consolidated offering, retailers, brands and logistics service providers (LSPs) gain access to a comprehensive end-to-end Returns Management solution, which allows them to streamline services for greater efficiency, waste reduction, and visibility.

“With e-commerce sales continuing to grow, retailers need to be prepared when it comes to returns, which were projected to hit $890 billion last year, representing 16.9% of annual retail sales and is more than double the return rate from 2019,” said Tim Robinson, corporate vice president, Returns, Blue Yonder. “We are excited to acquire Optoro, to enrich the capabilities available to our customers, allowing them to enhance their ability to manage returns with increased efficiency and effectiveness to meet the needs of consumers. This strategic acquisition affirms Blue Yonder's commitment to leading the industry, providing customers with unparalleled opportunities to refine their operations and driving transformative business success through a comprehensive returns solution.”

When combining Optoro’s capabilities with Blue Yonder’s existing returns management offering from a previous acquisition, Blue Yonder can now offer customers:

  • Enterprise-Grade Returns Processing: Enhances Blue Yonder's current offering with cloud-native, mature, feature-rich, processing and dispositioning capabilities to process returns in the warehouse and in-store. This completes the circularity of the journey of the returned item.
  • Enables Dedicated Returns Facilities: Allows retailers, brands and LSPs to efficiently manage specialized returns facilities, enhancing operational flexibility and efficiency.
  • In-Store Returns: The in-store app enables faster processing and automates inventory disposition to optimize recovery and maximize margin potential. By driving returns traffic in-store, retailers can capitalize on opportunities to resell products to enhance profitability and attract invaluable foot traffic with new-purchase potential.
  • Recommerce Capabilities: With configurable workflows to recommerce vendors built in, the solution enables retailers and brands to efficiently identify resalable inventory and sell it to the next-best option, promoting inventory circularity. This prevents backlogs in warehouses and reduces goods ending up in landfills.
  • Next-Level Returns Management: By extending Blue Yonder’s existing capabilities in returns initiation, decisioning and kiosks, Blue Yonder customers can complete the end-to-end journey needed to fully manage the returns process.

"Blue Yonder's acquisition of Optoro extends its returns management solution as an even more comprehensive offering,” said Jordan K. Speer, research director, IDC Retail Insights. “With the addition of Optoro, Blue Yonder will be able to provide more expanded capabilities that address the complexities of the returns lifecycle. This strategic move not only opens new opportunities to enhance operational efficiency but also aligns with the growing demand for sustainable practices. Blue Yonder's comprehensive approach addresses the downside of traditional returns processes, which often lead to poor profitability and lower customer satisfaction, by taking a transformative, dynamic approach to the entire end-to-end supply chain. The new combined offering has the potential to deliver great value to its users."

Blue Yonder customers who use the solution will receive the following benefits:

  • Enhanced Efficiency: With up to 18% of inventory often tied up in the returns process, optimizing returns management is crucial. Customers can accelerate receiving speeds by more than two times, enabling quicker inventory turnaround for resale and faster customer refunds.
  • Improved Financial Performance: Customers can achieve significant cost savings by reducing the volume of returns and cutting reverse logistics expenses. Additionally, they can streamline warehouse operations to lower labor costs and minimize fraud.
  • Loyalty-Winning Customer Experience: Customers can deliver both a simple, digital returns journey and an exceptional in-store returns experience, while offering fast refunds and exchanges to enhance customer satisfaction and foster brand loyalty.
  • Increased Sustainability: Customers will be able to reduce shipping miles, stock wastage, and stock transfers, as well as removing returns labels from parcels, all while improving sustainability.

“Optoro was founded when e-commerce was in its early days, with the foresight to solve the returns problem. Over time, we built enterprise-grade returns solutions to meet the needs of the most iconic retail brands,” said Amena Ali, CEO, Optoro. “Now, thanks to Blue Yonder’s growing customer base, we will realize the full potential of our vision, helping thousands of companies worldwide address the returns challenge. By seamlessly integrating with Blue Yonder, it will be easier than ever for companies to optimize their returns to improve the shopper experience, inventory planning, and overall profitability.”

Blue Yonder continues to be the only company with a comprehensive portfolio of solutions, from planning and execution to fulfillment and returns, to build more sustainable and profitable, end-to-end supply chains. This deal is Blue Yonder’s sixth acquisition in less than two years and is indicative of Blue Yonder's momentum in the supply chain management space. The acquisition allows the company to continue showcasing its strength in the retail and logistics industries. The acquisition agreement was closed by Blue Yonder and Optoro on Aug. 19, 2025.

About Blue Yonder

Blue Yonder is the world leader in end-to-end digital supply chain transformation. With a unified, AI-driven platform and multi-tier network, Blue Yonder empowers businesses to operate sustainably, scale profitably, and delight their customers—all at machine speed. A pioneer in applying AI solutions to the most complicated supply chain challenges, Blue Yonder’s modern innovations and unmatched industry expertise help more than 3,000 retailers, manufacturers, and logistics service providers confidently navigate supply chain complexity and disruption. blueyonder.com

“Blue Yonder” is a trademark or registered trademark of Blue Yonder Group, Inc. Any trade, product or service name referenced in this document using the name “Blue Yonder” is a trademark and/or property of Blue Yonder Group, Inc. All other company and product names may be trademarks, registered trademarks or service marks of the companies with which they are associated.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250818415001/en/

Contacts

Blue Yonder Corporate Communications:
mediarelationsteam@blueyonder.com
U.S.: +1 480-308-3037
EMEA: +39 335 7849149

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye